This is your chance to get involved - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

This is your chance to get involved


Pharmaceutical Technology Europe
Volume 22, Issue 6


Fedra Pavlou
Have you ever come across a new technology, process or problem in your profession and wanted to tell others or learn more about it? Or have you read through your issue of PTE and wished that the editors would publish more articles on a particular subject? If so, I'd really like to hear from you. This month sees the launch of PTE's annual readership survey ( http://www.pharmtech.com/survey2010). I always look forward to reading the results of this survey because it helps me to better understand what it is that you want from your monthly magazine and digital products. Ultimately, it helps me to do my job better and that is to provide the information that you want to read at the right time and in the right format.

If the opportunity of having direct input into PTE's editorial direction isn't enough of an incentive for you, then let me also tell you that all survey respondents will be entered into a prize draw to win an iPod Touch. The winner will be announced on our website ( http://www.pharmtech.com) in July as well as in PTE's eNewsletter.

I urge you take the time to complete this short online form, which is available on our website ( http://www.pharmtech.com/survey2010) and I guarantee it should take no longer than 5 minutes of your time. If you don't take part, I'll assume you think we're great just the way we are :-)

As always, thank you for your continued support.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology Europe,
Click here